EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus

Qin Ai, Sailan Wang, Ziyan Chen, Shuai Zheng, Zaixing Chen, Na Zhang iD, Yaowen Li, Huiping Liu, Yanyan Liu, Jiabin Li iD, Xiaohui Huang iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01609-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Qin Ai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Fosfomycin, Daptomycin, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of daptomycin and fosfomycin is attracting attention due to the rising resistance observed in methicillin-resistant Staphylococcus aureus (MRSA). Most studies indicate that this combination exhibits synergistic or additive antimicrobial activity against MRSA. However, its capacity to prevent resistance remains uncertain. In this study, we first investigated the antibacterial effect of daptomycin and fosfomycin on MRSA, followed by predicting MRSA resistance under the influence of different drugs using a resistance mutation selection window. Subsequently, we conducted preliminary analyses of drug resistance gene mutations in resistance mutants through gene sequencing technology. Additionally, we established an in vitro biofilm infection model to explore the internal tolerance associated with phenotypic alterations in biofilms and assess the combination’s ability to prevent drug resistance. Combination drug sensitivity experiments demonstrated that daptomycin and fosfomycin synergistically enhanced antimicrobial effects against the tested strains. This combination reduced the mutant prevention concentration of each drug and narrowed the selection window for drug-resistant mutations. Sequencing results indicated that specific resistance genes were mutated in the single-drug mutants, while no mutations were detected in the combination. Furthermore, the combination exhibited stronger inhibition and removal of biofilm compared to single agents. In conclusion, the daptomycin-fosfomycin combination displays a synergistic antibacterial effect against MRSA and shows enhanced capacity to prevent bacterial resistance, likely attributed to its ability to inhibit resistance gene mutations and exhibit superior anti-biofilm activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinDaptomycinMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsDrug SynergismBiofilmsMicrobial Sensitivity TestsMutationHumansStaphylococcal InfectionsDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

antibiotics resistancedaptomycinfosfomycinmethicillin-resistant Staphylococcus aureus

Substanzen

FosfomycinDaptomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Basic and Clinical Pharmacology, School of Pharmaceutical Sciences, Anhui Medical University, Hefei, China.
  • Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmaceutical Sciences, Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei, China.
  • Department of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Anhui Province Key Laboratory of Infectious Diseases & Institute of Bacterial Resistance, Anhui Medical University, Hefei, China.

ORCID-Profile: Na Zhang, Jiabin Li, Xiaohui Huang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ai, Q., Wang, S., Chen, Z., Zheng, S., Chen, Z., Zhang, N., Li, Y., Liu, H., Liu, Y., Li, J., & Huang, X. (2025). Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01609-24

Vancouver

Ai Q, Wang S, Chen Z, Zheng S, Chen Z, Zhang N, et al. Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01609-24

BibTeX
@article{Ai2025,
  author = {Ai, Qin and Wang, Sailan and Chen, Ziyan and Zheng, Shuai and Chen, Zaixing and Zhang, Na and Li, Yaowen and Liu, Huiping and Liu, Yanyan and Li, Jiabin and Huang, Xiaohui},
  title = {Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01609-24}
}
Kostenlos starten →